Procter & Gamble Hygiene and Health Care working capital

Per cent unless marked ×
Tap a line for its trendFY25Jun 2024FY24Jun 2023FY23 and earlierAlpha Plus
50.35×49.80×
FY23 and earlierEvery year the company has filed comes with Alpha Plus.
19.84×18.96×
206.08×191.99×
−135.89×−123.23×
19.20×9.54×
2.11×2.05×
0.70×1.22×
0.48×0.95×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHH₹6,923.50

Procter & Gamble Hygiene and Health Care Limited

· FMCG & Retail
₹ CrorePeersBAJAJCONJHSMcap ₹22,474 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
30/06/2023
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Inventory Days (DIO)49.8050.35——
Receivable Days (DSO)18.9619.84——
Payable Days (DPO)191.99206.08——
Cash Conversion Cycle (days)-123.23-135.89——
Working Capital Turnover9.5419.20——
Asset Turnover2.052.11——
Cash Conversion (CFO/Net Income)1.220.70——
CFO/EBITDA0.950.48——
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.